Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation: A Randomized Trial

NCT03140631 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT03140631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03140631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation: A Randomized Trial
Lead sponsor
University of Michigan
Phase
Phase 4
Overall status
Completed
Start date
March 23, 2017
Completion date
April 3, 2018
Enrollment
153 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, catheter ablation